US FTC sues ticket reseller for evading Taylor Swift's Eras tour ticket limits-February 2024-www.financetom.com

US FTC sues ticket reseller for evading Taylor Swift's Eras tour ticket limits

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FTC sues ticket reseller for evading Taylor Swift's Eras tour ticket limits

Aug 18, 2025 9:58 AM

(Reuters) -The U.S. Federal Trade Commission sued ticket reseller Key Investment Group for evading purchasing limits to buy up thousands of tickets to live events including Taylor Swift's Eras tour and resell them at a markup, according to a complaint filed in Maryland federal court on Monday.

Previous page： PriceSmart Insider Sold Shares Worth $1,078,978, According to a Recent SEC Filing Next page： United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

PriceSmart Insider Sold Shares Worth $1,078,978, According to a Recent SEC Filing

Sep 12, 2025

03:24 AM EDT, 09/12/2025 (MT Newswires) -- Michael McCleary, Executive Vice President - Finance, on September 09, 2025, sold 9,754 shares in PriceSmart ( PSMT ) for $1,078,978. Following the Form 4 filing with the SEC, McCleary has control over a total of 47,082 common shares of the company, with 47,082 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1041803/000162828025041965/xslF345X05/wk-form4_1757637759.xml ...

United Therapeutics Insider Sold Shares Worth $3,183,777, According to a Recent SEC Filing

Sep 12, 2025

03:25 AM EDT, 09/12/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & Chief Executive Officer, on September 10, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,183,777. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled...

Summit Therapeutics Insider Bought Shares Worth $5,984,756, According to a Recent SEC Filing

Sep 12, 2025

03:27 AM EDT, 09/12/2025 (MT Newswires) -- Mahkam Zanganeh, 10% Owner, Director, Co-Chief Executive Officer, on September 10, 2025, executed a purchase for 338,394 shares in Summit Therapeutics ( SMMT ) for $5,984,756. Following the Form 4 filing with the SEC, Zanganeh has control over a total of 591,831,532 common shares of the company, with 31,000 shares held directly and...

Navitas Semiconductor Insider Sold Shares Worth $7,249,298, According to a Recent SEC Filing

Sep 12, 2025

03:21 AM EDT, 09/12/2025 (MT Newswires) -- Brian Long, Director, on September 09, 2025, sold 1,247,700 shares in Navitas Semiconductor ( NVTS ) for $7,249,298. Following the Form 4 filing with the SEC, Long has control over a total of 2,693,039 Class A common shares of the company, with 22,048 shares held directly and 2,670,991 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1821769/000120101025000017/xslF345X05/wk-form4_1757640119.xml...